Moberg's derma tech enters Phase II; West Pharma counting on delivery sales;

 @DamianFierce: Ever wonder exactly how wireless drug delivery works? Well, wonder no longer. News | Follow @DamianFierce

> Following positive Phase I results for Limtop, Sweden's Moberg Derma is launching Phase II trials for the dermal delivery technology. More

> West Pharma is betting on its proprietary drug delivery technologies to drive sales growth over the next 5 years. Report

> Medimetrics is touting the recent certification of the IntelliCap system, which is designed to deliver small-molecule drugs into the gastrointestinal tract. Article

> Diabecline, pharmaCline's antibiotic ointment that uses a proprietary delivery system, won bronze honors for Best New Pharmaceutical Product at the Edison Awards this month. Release

And Finally... Drug developers have spent millions in R&D to improve controlled-release platforms, but perhaps they could have saved time and money by just watching 1983's The Witches and copying Formula 86, a delayed-action mousemaker. Blog post

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.